
ORTIF
Healthcare · Medical Devices · $10.8M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 19, 2022 | After the close | — | -0.02 | — |
| Dec 21, 2021 | After the close | -0.03 | -0.06 | -100.0% |
| Sep 30, 2021 | After the close | -0.03 | -0.03 | 0.0% |
| May 31, 2021 | After the close | -0.02 | -0.04 | -100.0% |
| Apr 30, 2021 | Time not confirmed | 0.00 | -0.03 | — |
| Dec 17, 2020 | After the close | -0.03 | -0.03 | 0.0% |
| Sep 24, 2020 | After the close | 0.00 | -0.02 | — |
| May 29, 2020 | After the close | 0.00 | -0.02 | — |
| Apr 30, 2020 | Time not confirmed | 0.00 | -0.03 | — |
| Jan 31, 2020 | Time not confirmed | 0.00 | -0.01 | — |
| Oct 31, 2019 | Time not confirmed | 0.00 | -0.02 | — |
| Jul 31, 2019 | Time not confirmed | 0.00 | -0.02 | — |
| Apr 30, 2019 | Time not confirmed | 0.00 | -0.02 | — |
Ortho Regenerative Technologies Inc., an orthopaedic and sports medicine biologics company, engages in the research and development of novel therapeutic soft tissue repair technologies to enhance the success rate of sports medicine surgeries in Canada. It develops Ortho-R, a formulation for rotator cuff repair; Ortho-M, a biopolymer for meniscus repair; Ortho-C, a biopolymer for articular cartilage repair; and…
| Jan 31, 2019 | Time not confirmed | 0.00 | -0.02 | — |
| Oct 31, 2018 | Time not confirmed | 0.00 | -0.02 | — |
| Jul 31, 2018 | Time not confirmed | 0.00 | -0.01 | — |
| Apr 30, 2018 | Time not confirmed | 0.00 | -0.02 | — |
| Jan 31, 2018 | Time not confirmed | 0.00 | -0.04 | — |